7096 — StemCell Institute Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for StemCell Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 213 | 279 | 441 | 566 | 218 |
| Depreciation | |||||
| Non-Cash Items | 17.8 | 40 | -16.8 | -120 | 16.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 142 | -324 | -210 | -106 | -317 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 469 | 99.7 | 335 | 468 | 73.5 |
| Capital Expenditures | -204 | -59.9 | -202 | -575 | -527 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 609 | -225 | -610 | 316 | -218 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 404 | -285 | -812 | -259 | -745 |
| Financing Cash Flow Items | — | -0.001 | — | -0.002 | 407 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 644 | -0.869 | -1.33 | 147 | 232 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,518 | -186 | -478 | 355 | -404 |